Ozempic and other GLP-1 drugs have become extremely popular for their ability to manage Type 2 diabetes symptoms and spur ...

Semaglutide, the active ingredient in Ozempic and Wegovy, is a glucagon-like peptide-1 (GLP-1) receptor agonist taken as a ...

Managing type 2 diabetes requires more than just taking a pill. It is a daily commitment to keeping blood sugar levels in ...

Women using Ozempic and similar drugs are reporting changes in the vulva area, termed 'Ozempic vulva,' including sagging, ...

Ozempic’s active ingredient is semaglutide, which belongs to a class of medications called incretin mimetics, and was approved as a treatment for type 2 diabetes via a 1-milligram injection in 2017.

Ozempic — which mimics the body’s naturally occurring GLP-1 hormone to make people feel full and eat less — treats diabetes and can spur weight loss.

Ozempic is available in the UK for type 2 diabetes patients with a prescription. Wegovy and Mounjaro is available to NHS patients, but only through specialist weight management services.